Classification Term: 170967

Thromboxanes (ontology term: 0e3509d404523985ed90f7792432b23c)

found 7 associated metabolites at sub_class metabolite taxonomy ontology rank level.

Ancestor: Eicosanoids

Child Taxonomies: There is no child term of current ontology term.

Thromboxane B2

(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid

C20H34O6 (370.2355)


Thromboxanes. A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). -- Pubchem. Thromboxanes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Thromboxanes

   

Thromboxane A2

(5Z,9α,11α,13E,15S)-9,11-Epoxy-15-hydroxythromboxa-5,13- dien-1-oic acid

C20H32O5 (352.225)


A thromboxane which is produced by activated platelets and has prothrombotic properties: it stimulates activation of new platelets as well as increases platelet aggregation.

   

Thromboxane A2

7-[3-(3-Hydroxy-1-octenyl)-2,6-dioxabicyclo[3.1.1]hept-4-yl]-[1S-[1alpha,3alpha(1E,3R*),4beta(Z),5alpha]]-5-heptenoic acid

C20H32O5 (352.225)


Thromboxane A2 is an unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS).Thromboxanes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways.

   

Thromboxane B2

9S,11,15S-trihydroxy-thromboxa-5Z,13E-dien-1-oic acid

C20H34O6 (370.2355)


A member of the class of thromboxanes B that is (5Z,13E)-thromboxa-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15.

   

7-[(2r,3s,4s)-4,6-dihydroxy-2-[(1e,3s)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid

7-[(2r,3s,4s)-4,6-dihydroxy-2-[(1e,3s)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid

C20H34O6 (370.2355)


   

7-[(2r,3s,4s)-4-hydroxy-2-[(1e,3s)-3-hydroxyoct-1-en-1-yl]-6-oxooxan-3-yl]hept-5-enoic acid

7-[(2r,3s,4s)-4-hydroxy-2-[(1e,3s)-3-hydroxyoct-1-en-1-yl]-6-oxooxan-3-yl]hept-5-enoic acid

C20H32O6 (368.2199)


   

thromboxane b>2<

thromboxane b>2<

C20H34O6 (370.2355)